logo

3BBLACKBIO vs ZOTA: Stock Comparison

3B BLACKBIO DX vs ZOTA HEALTH CAREUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

ZOTA HEALTH CARE is the larger company by market capitalisation. 3B BLACKBIO DX shows a higher ROE, a higher dividend yield and lower leverage, while ZOTA HEALTH CARE shows a lower P/E and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

3BBLACKBIO leads 8; ZOTA leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

3BBLACKBIOZOTA

Valuation lens

What price are you paying?

Market CapContext only
₹1,143 Cr
₹4,714 Cr
P/E RatioZOTA has the lower reading
20.58x
0x ✓
P/B Ratio3BBLACKBIO has the lower reading
3.52x ✓
6.8x
EPS3BBLACKBIO has the higher reading
₹11.11 ✓
₹-12.58
Book ValueContext only
₹386.41
₹201.01
Dividend Yield3BBLACKBIO has the higher reading
0.38% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ZOTA is the larger company
₹4,714 Cr vs ₹1,143 Cr
P/E Ratio
ZOTA has a lower P/E
0x vs 20.58x
P/B Ratio
3BBLACKBIO has a lower P/B
3.52x vs 6.8x
EPS
3BBLACKBIO has higher earnings per share
₹11.11 vs ₹-12.58
Dividend Yield
3BBLACKBIO has a higher dividend yield
0.38% vs 0%
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 0%
Qtr Sales Growth
ZOTA has stronger quarterly sales growth
0% vs -5.48%
Qtr Profit Growth
ZOTA has stronger quarterly profit growth
0% vs -8.43%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

Metric3BBLACKBIOZOTA
Sector—Healthcare
Industry—Pharmaceuticals

Price

Metric3BBLACKBIOZOTA
Live Price₹1,331.2₹1,359.9
Day Change-7.96%-3.51%
Volume43,44344,643
52-Week High₹1,740₹1,740
52-Week Low₹1,085₹1,022
Distance from 52W High-23.49%-21.84%

Valuation

Metric3BBLACKBIOZOTA
Market Cap₹1,143 Cr₹4,714 Cr
P/E Ratio20.58x0x
P/B Ratio3.52x6.8x
EPS₹11.11₹-12.58
Book Value₹386.41₹201.01
Dividend Yield0.38%0%

Growth

Metric3BBLACKBIOZOTA
Revenue Growth (TTM YoY)0%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-5.48%0%
Qtr Profit Growth-8.43%0%

Profitability & Leverage

Metric3BBLACKBIOZOTA
ROE18.07%-10.64%
ROCE17.44%-8.71%
Net Margin42.23%-13.98%
Operating Margin54.4%-11.6%
Debt to Equity0.01x0.04x

Shareholding

As of Jun 2026 • change vs previous quarter
Metric3BBLACKBIOZOTA
Promoter Holding38.48%▲ 0.02 pp49.38%
FII Holding2.5%▼ 0.07 pp7.92%▼ 0.29 pp
DII Holding2.15%▲ 0.17 pp6.75%▲ 0.35 pp
Public Holding54.4%▼ 0.11 pp35.96%▼ 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: 3B BLACKBIO DX and ZOTA HEALTH CARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.